DERMATITIS, ATOPIC
Clinical trials for DERMATITIS, ATOPIC explained in plain language.
Never miss a new study
Get alerted when new DERMATITIS, ATOPIC trials appear
Sign up with your email to follow new studies for DERMATITIS, ATOPIC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shot could bring relief to teens with severe eczema
Disease control Not yet recruitingThis study tests a new drug called MG-K10 in 180 teenagers with moderate-to-severe eczema that hasn't improved with creams. The drug is given as a shot and aims to clear skin and reduce itching. Participants will be randomly assigned to get the drug or a placebo, and neither they…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE3 • Sponsor: Shanghai Mabgeek Biotech.Co.Ltd • Aim: Disease control
Last updated May 26, 2026 07:52 UTC
-
Eczema cream showdown: which ointment works better?
Disease control Not yet recruitingThis study compares two prescription ointments—crisaborole and tacrolimus—for treating mild-to-moderate eczema in people aged 5 to 25. Researchers will measure how well each ointment clears skin rashes and reduces itch. The goal is to find which treatment works better and is safe…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE4 • Sponsor: Cairo University • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
New eczema drug enters first human safety trials
Symptom relief Not yet recruitingThis early-stage study tests a new drug called DCY636 for safety and how the body processes it. It includes healthy volunteers and people with moderate to severe eczema (atopic dermatitis). The goal is to see if the drug is safe enough for further testing, not to cure the conditi…
Matched conditions: DERMATITIS, ATOPIC
Phase: PHASE1 • Sponsor: Novartis Pharmaceuticals • Aim: Symptom relief
Last updated May 26, 2026 07:23 UTC